Biotek-snakken — Januar 2023
-
-
2cureX announces final results regarding 2022 goals https://www.proinvestor.com/boards/109666
-
-
XBrane styrke købssignal? 91,90
I dag %
+6,74% -
Red Eye Life Science outlook 2023 med meget positiv præsentation af Xbrane mellem 37.43 og 46.40 inde i videoen. Iforhold til andre biosimilar selskaber, ser XBrane ud til at være markant undervurderet. https://www.redeye.se/video/event-presentation/871986/redeye-life-science-outlook-2023?utm_source=video&utm_medium=email
-
Imponerende at XBrane bare buldrer videre opad i det her depressive marked +4%
…..Men markedsværdien af selskabet er MARKANT lavere iforhold til de få konkurrenter som findes indenfor Biosimilarer. Selvom XBrane er ligeså langt fremme og har en del kurstriggere i 2023.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind